1. Risk of fatal pulmonary events in patients with advanced non-small-cell lung cancer treated with EGF receptor tyrosine kinase inhibitors: a comparative meta-analysis;Abdel-Rahman;Future Oncol.,2015
2. Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis;Abdel-Rahman;Future Oncol.,2015
3. Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis;Abdel-Rahman;Expert Opin. Drug Saf.,2015
4. Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors; a Meta-analysis;Abdel-Rahman;Immunotherapy,2015
5. Risk of endocrine complications in cancer patients treated with immune check point inhibitors; a meta-analysis;Abdel-Rahman;Future Oncol.,2015